IP Library Granted Patent US 10,502,744
Granted Patent B2
US 10,502,744 · App. 15/906,241 · Granted Dec 10, 2019

1,1 ′-[[(Substituted alkyl)imino]bis(alkylene)]bis-ferrocenes and their use in I electrochemical assays by labelling substrates of interest

Inventors: Barrie Marsh (Trowbridge, GB); Christopher Frost (Bath and North East Somerset, GB); David Pearce (Trowbridge, GB)
Assignee: Atlas Genetics Limited
G01N33/58C07F17/02C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,502,744
App. No.
15/906,241
Granted
Dec 10, 2019
Kind
B2
Abstract

Compounds of general formula I wherein Fc and Fc′ may be the same or different and are substituted ferrocenyl moieties having at least one ring substituent selected from sulfur-containing groups, phosphorus-containing groups, iodo, chloro, silyl, fluoroalkyl groups containing two or more fluorine atoms, heteroaryl, substituted phenyl, and cyano, wherein if present as sole substituent the cyano group is located on the proximal cyclopentadienyl ring; X is a spacer. Y is a spacer, Z is a spacer; and R is a linker group. Compound I may be used to make labelled substrates, functionalised compounds for making labelled substrates and may be used as labels in an electrochemical assay.

Claims (4)

1. A 6-(bis((2-tert-butyl-sulfonylferrocenyl)1-methylferrocenyl)amino)hexan-1-ol compound of the formula:

2. A 6-(bis((2-di-tert-butyl-phosphinyl-ferrocenyl) 1-methylferrocenyl)amino)hexan-1-ol compound of the formula:

3. A 6-(bis((2-tert-butyl-sulfinylferrocenyl)1-methylferrocenyl)amino)hexan-1-ol compound of the formula:

4. A 6-(bis((2-tert-butyl-sulfidylferrocenyl)1-methylferrocenyl)amino)hexan-1-ol compound of the formula:

Assignments (6)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
CHANGE OF NAME Recorded Dec 12, 2019
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 051264/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2018
From: MARSH, BARRIE; FROST, CHRISTOPHER; PEARCE, DAVID
To: ATLAS GENETICS LIMITED
Reel/Frame 045238/0464 →
Priority Claims (1)
GB 1211157.1 · Jun 22, 2012 · national
Continuity (2)
Continuation 14410296
Related Publication 20180252723A1 · Sep 6, 2018
Cited By (1)
US 12,601,703